- Home
- BBIO vs BOOT Comparison
BBIO vs BOOT Comparison
Compare BBIO & BOOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- BOOT
- Stock Information
- Founded
- BBIO 2015
- BOOT 1978
- Country
- BBIO United States
- BOOT United States
- Employees
- BBIO N/A
- BOOT N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- BOOT Clothing/Shoe/Accessory Stores
- Sector
- BBIO Health Care
- BOOT Consumer Discretionary
- Exchange
- BBIO Nasdaq
- BOOT Nasdaq
- Market Cap
- BBIO 4.9B
- BOOT 4.1B
- IPO Year
- BBIO 2019
- BOOT 2014
- Fundamental
- Price
- BBIO $23.24
- BOOT $136.26
- Analyst Decision
- BBIO Strong Buy
- BOOT Strong Buy
- Analyst Count
- BBIO 13
- BOOT 11
- Target Price
- BBIO $46.92
- BOOT $164.36
- AVG Volume (30 Days)
- BBIO 1.7M
- BOOT 1.1M
- Earning Date
- BBIO 11-12-2024
- BOOT 10-28-2024
- Dividend Yield
- BBIO N/A
- BOOT N/A
- EPS Growth
- BBIO N/A
- BOOT N/A
- EPS
- BBIO N/A
- BOOT 4.98
- Revenue
- BBIO $217,765,000.00
- BOOT $1,758,043,000.00
- Revenue This Year
- BBIO $3,690.39
- BOOT $15.96
- Revenue Next Year
- BBIO N/A
- BOOT $14.07
- P/E Ratio
- BBIO N/A
- BOOT $27.33
- Revenue Growth
- BBIO 2209.77
- BOOT 3.51
- 52 Week Low
- BBIO $21.62
- BOOT $68.37
- 52 Week High
- BBIO $44.32
- BOOT $169.83
- Technical
- Relative Strength Index (RSI)
- BBIO 41.84
- BOOT 44.55
- Support Level
- BBIO $21.72
- BOOT $129.35
- Resistance Level
- BBIO $27.57
- BOOT $136.36
- Average True Range (ATR)
- BBIO 1.42
- BOOT 4.86
- MACD
- BBIO -0.23
- BOOT 0.95
- Stochastic Oscillator
- BBIO 25.98
- BOOT 85.60
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, acoramidis (AG10), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About BOOT Boot Barn Holdings Inc.
Boot Barn Holdings Inc operates specialty retail stores. The company sells western and work-related footwear, apparel, and accessories in the United States. It is a single operating segment, which includes net sales generated from its retail stores and e-commerce websites.